114 related articles for article (PubMed ID: 3784119)
41. [6. Inspection of Hepatocellular Carcinoma 4: Nuclear Medicine Scan].
Odagiri H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jun; 72(6):522-9. PubMed ID: 27320156
[No Abstract] [Full Text] [Related]
42. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
43. Hepatoma visualization with Tc-99m pyridoxylidene glutamate.
Utz JA; Lull RJ; Anderson JH; Lambrecht RW; Brown JM; Henry W
J Nucl Med; 1980 Aug; 21(8):747-9. PubMed ID: 6249896
[TBL] [Abstract][Full Text] [Related]
44. [Preparation of 99mTc-Sn-N-(2,6-diethylacetanilido)-imidodiacetate from ROTOP-EHIDA].
Berger R; Syhre R
Radiobiol Radiother (Berl); 1986; 27(6):727-32. PubMed ID: 3575680
[No Abstract] [Full Text] [Related]
45. TC-99m(Sn)-N-pyridoxylaminates: a new series of hepatobiliary imaging agents.
Kato-Azuma M
J Nucl Med; 1982 Jun; 23(6):517-24. PubMed ID: 7077403
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agent].
Toyama H; Ito K; Komori Y; Sugioka A; Shibata K; Komai S; Fujiwara T; Ishikawa E; Tomita K; Fujii N
Kaku Igaku; 1995 Mar; 32(3):323-9. PubMed ID: 7739162
[TBL] [Abstract][Full Text] [Related]
47. [Estimation of 99mTc-GSA receptor amount by non-linear 3-compartment model: ligand-receptor binding model without blood sampling].
Fujimori K; Shounai T; Koito K; Yoshida S; Takeda M; Yama N; Katsuramaki T; Furuhata T; Hirata K; Hareyama M
Kaku Igaku; 1999 Sep; 36(7):753-60. PubMed ID: 10547985
[TBL] [Abstract][Full Text] [Related]
48. (99m)Tc sulfur colloid and (99m)Tc mebrofenin hepatobiliary functional liver imaging in normal and diabetic rats.
Al-Saeedi F; Loutfi I
Med Princ Pract; 2011; 20(2):129-32. PubMed ID: 21252566
[TBL] [Abstract][Full Text] [Related]
49. Hepatic benign vascular tumor in infancy: correlative imaging.
Rosen PR; Mewborne EB; Macpherson RI; Nusynowitz ML
Clin Pediatr (Phila); 1982 Mar; 21(3):180-2. PubMed ID: 7056018
[TBL] [Abstract][Full Text] [Related]
50. [Efficiency of hepatosplenic scintigraphy in the detection of hepatic metastases in gastric cancer].
Massardo T; Orellana P; Burgos R; Csendes A; Muñoz S; Braghetto I; Raggio R; Gonzalez P; Nagel J
Rev Med Chil; 1985 Feb; 113(2):129-33. PubMed ID: 4081392
[No Abstract] [Full Text] [Related]
51. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT).
Sugimura K; Nishiyama S; Narabayashi I
Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432
[No Abstract] [Full Text] [Related]
52. [Pharmacokinetics of 99m Tc-technephyte in radionuclide studies of the liver and spleen].
Ovdienko NI; Starovoĭtova LP; Kodina GE; Malysheva AO; Tul'skaia TI
Med Radiol (Mosk); 1987 Jul; 32(7):63-7. PubMed ID: 3613926
[TBL] [Abstract][Full Text] [Related]
53. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
Vera DR; Krohn KA; Scheibe PO; Stadalnik RC
IEEE Trans Biomed Eng; 1985 May; 32(5):312-22. PubMed ID: 3997184
[No Abstract] [Full Text] [Related]
54. Usefulness of Tc-99m-GSA scintigraphy for liver surgery.
Kaibori M; Ha-Kawa SK; Maehara M; Ishizaki M; Matsui K; Sawada S; Kwon AH
Ann Nucl Med; 2011 Nov; 25(9):593-602. PubMed ID: 21800021
[TBL] [Abstract][Full Text] [Related]
55. Hepatobiliary scintigraphy as a liver function test.
Heyman S
J Nucl Med; 1994 Mar; 35(3):436-7. PubMed ID: 8113891
[No Abstract] [Full Text] [Related]
56. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
57. Tc-NGA imaging in liver transplantation: preclinical studies.
Woodle ES; Vera DR; Stadalnik RC; Ward RE
Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
[TBL] [Abstract][Full Text] [Related]
58. Area between the hepatic and heart curves of (99m)Tc-galactosyl-human serum albumin scintigraphy represents liver function and disease progression for preoperative evaluation in hepatocellular carcinoma patients.
Harada K; Mizuguchi T; Katagiri Y; Kawamoto M; Nakamura Y; Meguro M; Ota S; Sasaki S; Miyanishi K; Sonoda T; Mori M; Shinomura Y; Kato J; Hirata K
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):667-73. PubMed ID: 22179579
[TBL] [Abstract][Full Text] [Related]
59. [The lung and mediastinal metastases of a hepatocellular carcinoma. Enhancement in the liver function scintigram with 99mTc-IODIDA].
Link TM; Anger K; Hebestreit HP; Bade J
Rofo; 1992 Jul; 157(1):101-2. PubMed ID: 1322200
[No Abstract] [Full Text] [Related]
60. Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin.
Miki K; Kubota K; Kokudo N; Inoue Y; Bandai Y; Makuuchi M
J Nucl Med; 1997 Nov; 38(11):1798-807. PubMed ID: 9374359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
